Scientific Reports (Feb 2022)

Communicate hope to motivate the public during the COVID-19 pandemic

  • Michael Bang Petersen,
  • Lasse Engbo Christiansen,
  • Alexander Bor,
  • Marie Fly Lindholt,
  • Frederik Jørgensen,
  • Rebecca Adler-Nissen,
  • Andreas Roepstorff,
  • Sune Lehmann

DOI
https://doi.org/10.1038/s41598-022-06316-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 7

Abstract

Read online

Abstract How should health authorities communicate to motivate the public to comply with health advice during a prolonged health crisis such as a pandemic? During the SARS-CoV-2 pandemic, for example, people have had to comply with successive restrictions as the world faced multiple races between controlling new waves of the virus and the development and implementation of vaccines. Here, we examine how health authorities and governments most effectively motivate the public by focusing on a specific race: between the Alpha variant and the implementation of the first generation of COVID-19 vaccinations in the winter of 2021. Following prior research on crisis communication, we focus on appeals to fear and hope using communicative aids in the form of visualizations based on epidemiological modelling. Using a population-based experiment conducted in United States ( $$N = 3,022$$ N = 3 , 022 ), we demonstrate that a hope-oriented visual communication aid, depicting the competing effects on the epidemic curve of (1) a more infectious variant and (2) vaccinations, motivates public action more effectively than a fear-oriented visual communication, focusing exclusively on the threat of the new variant. The importance of the implementation of such hope-oriented messages is further highlighted by cross-national representative surveys from eight countries ( $$N = 3,995$$ N = 3 , 995 ), which demonstrate that feelings of fear towards the Alpha variant alone were insufficient to activate strong compliance. Overall, these findings provide general insights into the importance of hope as a health communication strategy during the COVID-19 pandemic and beyond.